Register for our free email digests:
Glaxo Wellcome PLC
Division of GlaxoSmithKline PLC
Latest From LifeScan Inc.
The medtech industry has traditionally grown through innovation – new products with improved features and benefits have fueled revenue growth. However, innovation alone does not garner the price premium it once did, and manufacturers must decide whether to pursue a value brand strategy alongside their traditional premium brand, says global management consulting firm Simon-Kucher & Partners.
In a new partnership, Qualcomm is again looking to put its wireless and data management technologies to use to enhance a more traditional medical device.
The global diabetes management devices market is expected to exceed $11.2bn by 2020, driven largely by the rising diabetes epidemic. This, in turn, is fueling significant innovation such as next-generation, automated artificial pancreas systems and miniaturized, less-invasive wireless technologies that can continuously track and analyze glucose levels in real-time. This feature looks more closely at these and other potentially groundbreaking new technologies, as well as the competitive landscape of the two major product segments – insulin pumps and blood glucose monitors.
Many medtech companies reported their sales and earnings for all of 2016, along with projections for 2017, at the end of January or early February. Medtech Insight has examined their reports as well as the comments of the analysts who track these companies to highlight a few that had especially good years, some that had down years, and some lesser-known companies worth watching in the future.
- Therapeutic Areas
- Western Europe
- Parent & Subsidiaries
- GlaxoSmithKline PLC
- Senior Management
Robert A Ingram, CEO
J. D Coombe, Executive Dir., Fin & Investor Relations
James Neidel, Executive Dir., R&D
Richard Sykes, Chmn.
- Contact Info
Glaxo Wellcome PLC
Phone: (44) 1714 9340
London, W1X 6BQ
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.